 IRVINE, Calif., June 07, 2021 GLOBE NEWSWIRE -- Inari Medical, Inc. NASDAQ: NARI Inari a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced strongly positive interim results of the first 250 deep vein thrombosis DVT patients enrolled in the ClotTriever Outcomes Registry CLOUT. This latest data showed that ClotTriever removed 100 of the blood clots in the majority of DVT patients without the need for thrombolytic drugs in short single-session procedures. The late-breaking data was presented virtually at NCVH 2021 by principal investigator, Robert Beasley, MD, an interventional radiologist at Palm Vascular Center in Miami, FL. 